Company Profile
Quest Diagnostics Stock Price, News & Analysis
- Ticker:
- DGX
- Exchange:
- NYSE
- Sector:
- Diagnostics and Healthcare Services
- Location:
- Headquartered in the United States and listed on NYSE, Quest Diagnostics is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.
Stock performance
197.18 USD (+1.86%)
Close
Last updated: June 23, 2026 at 00:00
21.83B USD
Market cap
Why the stock is moving
DGX is trading more like a diagnostics and healthcare services name than a classic biotech binary. Investors tend to focus on testing volume, reimbursement, and operating leverage, so the stock usually responds to utilization trends and earnings cadence rather than one-off clinical catalysts.
Company overview
Business overview
Quest Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Quest Diagnostics is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.
Business Model Characteristics
Quest Diagnostics is a commercial-tools story where install base, recurring demand, and product adoption drive the narrative more than one-off clinical events.
Position Within the Biotechnology Landscape
Compared with therapeutic biotech names, Quest Diagnostics sits on a different part of the landscape where utilization, customer demand, and product refresh tend to matter more than binary FDA events.
Future catalysts
Over the next three months, the most important checkpoints are earnings, reimbursement commentary, and any update on testing demand or specialty diagnostics mix.
Investors also watch acquisition activity, health-plan access, and workflow adoption because they can shift the margin profile without relying on a single trial event.
Conference appearances and peer commentary may matter, but the stock usually moves more on utilization and pricing detail than on binary FDA headlines.
Advanced diagnostics adoption remains the longer-term upside lever, especially where precision medicine and companion testing expand the addressable market.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026
Source: Quest Diagnostics
- 04
- 05
Quest Diagnostics Declares Quarterly Cash Dividend
Source: Quest Diagnostics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Quest Diagnostics (DGX)?
Quest Diagnostics (DGX) most recently closed at 197.18 USD, a +1.86% move versus the previous session.
What is the market cap of Quest Diagnostics (DGX)?
Quest Diagnostics currently has a market capitalization of 21.83B USD on BioPharmSignal.
What does Quest Diagnostics do?
Quest Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
On which exchange is DGX stock listed?
Quest Diagnostics (DGX) is associated with NYSE, Headquartered in the United States and listed on NYSE, Quest Diagnostics is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles., Diagnostics and Healthcare Services.
What is Quest?
Quest Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
Which conditions is Quest Diagnostics targeting with Quest?
Quest Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow. Over the next three months, the most important checkpoints are earnings, reimbursement commentary, and any update on testing demand or specialty...
How does Quest Diagnostics describe recent progress with Quest?
Over the next three months, the most important checkpoints are earnings, reimbursement commentary, and any update on testing demand or specialty diagnostics mix. Investors also watch acquisition activity, health-plan access, and workflow adoption because they can shift the margin profile without relying on a single trial event. Conference appearances and...
What is Diagnostics?
Quest Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.